.175 by the end of next week !!!Based on update .... Vaxil has commenced the in vivo (animal) study for our COVID-19 vaccine candidate, under the guidance of Dr. Hagin, Director of the Allergy and Clinical Immunology Unit at the Tel Aviv Medical Center. The first animal injection was administered on July 14, 2020. This experiment which will evaluate the immune response to Vaxils COVID-19 vaccine candidate, will continue for several weeks after which we will evaluate the results and determine next steps.